• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺囊性病变的处理。

Management of Pancreatic Cystic Lesions.

机构信息

Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy,

Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.

出版信息

Dig Surg. 2020;37(1):1-9. doi: 10.1159/000496509. Epub 2019 Jan 11.

DOI:10.1159/000496509
PMID:30636253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7360492/
Abstract

BACKGROUND

The prevalence of undefined pancreatic cystic neoplasms (PCNs) is high in the general population, increasing with patient age. PCNs account for different biological entities with different potential for malignant transformation. The clinician must balance his or her practice between the risk of surgical overtreatment and the error of keeping a malignant lesion under surveillance.

METHODS

We review and discuss the clinical management of PCNs. Specifically, we analyze the main features of PCNs from the surgeon's point of view, as they present in the outpatient clinic. We also review the different consensus guidelines, address recent controversies in the literature, and present the current clinical practice at 4 different European Centers for pancreatic surgery.

RESULTS

The main features of PCNs were analyzed from the surgeon's point of view as they present in the outpatient clinic. All aspects of surgical management were discussed, from indications for surgery to intraoperative management and surveillance strategies.

CONCLUSIONS

Management of PCNs requires a selective approach with the aim of minimizing clinically relevant diagnostic mistakes. Through the evaluation of clinical and radiological features of a PCN, the surgeon can elaborate on a diagnostic hypothesis and assess malignancy risk, but the final decision should be tailored to the individual patient's need.

摘要

背景

在普通人群中,未定义的胰腺囊性肿瘤(PCN)的患病率很高,并且随着患者年龄的增长而增加。PCN 代表不同的生物学实体,具有不同的恶性转化潜力。临床医生必须在手术过度治疗的风险和对恶性病变进行监测的错误之间取得平衡。

方法

我们回顾和讨论了 PCN 的临床管理。具体来说,我们从外科医生的角度分析了 PCN 的主要特征,因为它们出现在门诊中。我们还回顾了不同的共识指南,讨论了文献中的最新争议,并介绍了 4 个不同的欧洲胰腺外科中心的当前临床实践。

结果

从外科医生在门诊中遇到的角度分析了 PCN 的主要特征。讨论了手术管理的各个方面,包括手术适应证、术中管理和监测策略。

结论

PCN 的管理需要采用有选择性的方法,旨在最大程度地减少临床相关的诊断错误。通过评估 PCN 的临床和影像学特征,外科医生可以对诊断假设进行阐述,并评估恶性风险,但最终决策应根据患者的个体需求进行调整。

相似文献

1
Management of Pancreatic Cystic Lesions.胰腺囊性病变的处理。
Dig Surg. 2020;37(1):1-9. doi: 10.1159/000496509. Epub 2019 Jan 11.
2
Pancreatic Cystic Lesions: Diagnostic, Management and Indications for Operation. Part I.胰腺囊性病变:诊断、管理及手术指征。第一部分
Chirurgia (Bucur). 2017 Mar-Apr;112(2):97-109. doi: 10.21614/chirurgia.112.2.97.
3
Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.肝移植受者胰腺囊性肿瘤的患病率和结局。
World J Gastroenterol. 2017 Dec 28;23(48):8526-8532. doi: 10.3748/wjg.v23.i48.8526.
4
Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.血管内皮生长因子,一种新型的、高度准确的胰腺液生物标志物,用于诊断浆液性胰腺囊肿。
J Am Coll Surg. 2014 Apr;218(4):608-17. doi: 10.1016/j.jamcollsurg.2013.12.019. Epub 2013 Dec 24.
5
Pancreatic cystic neoplasms: a review of preoperative diagnosis and management.胰腺囊性肿瘤:术前诊断和治疗的综述。
J Zhejiang Univ Sci B. 2013 Mar;14(3):185-94. doi: 10.1631/jzus.B1200283.
6
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines.胰腺囊性肿瘤的诊断与处理:现有证据与指南。
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):676-689. doi: 10.1038/s41575-019-0195-x. Epub 2019 Sep 16.
7
[Strategy in intraductal papillary mucinous neoplasm of the pancreas].[胰腺导管内乳头状黏液性肿瘤的治疗策略]
Gastroenterol Hepatol. 2012 Nov;35(9):652-9. doi: 10.1016/j.gastrohep.2012.05.009. Epub 2012 Jul 24.
8
Follow-up of asymptomatic pancreatic cysts in clinical practice: A vignette questionnaire.临床实践中无症状胰腺囊肿的随访:一份病例问卷。
Pancreatology. 2016 May-Jun;16(3):416-22. doi: 10.1016/j.pan.2016.02.007. Epub 2016 Feb 23.
9
Surveillance of Pancreatic Cystic Neoplasms.胰腺囊性肿瘤监测。
Gastrointest Endosc Clin N Am. 2023 Jul;33(3):613-640. doi: 10.1016/j.giec.2023.03.010. Epub 2023 Apr 24.
10
Premalignant cystic neoplasms of the pancreas.胰腺的癌前囊性肿瘤。
Semin Oncol. 2015 Feb;42(1):70-85. doi: 10.1053/j.seminoncol.2014.12.007. Epub 2014 Dec 9.

引用本文的文献

1
Identifying Neoplastic Versus Non-neoplastic Pancreatic Cystic Lesions-What Is the Current Evidence?鉴别胰腺囊性肿瘤性病变与非肿瘤性病变——当前有哪些证据?
Dig Dis Sci. 2025 Aug 22. doi: 10.1007/s10620-025-09320-4.
2
A 39 year-old woman with a mucinous cystadenocarcinoma of pancreas in the left upper abdomen and right lung: A case report.一名39岁女性,左上腹及右肺患有胰腺黏液性囊腺癌:病例报告。
Int J Surg Case Rep. 2025 Sep;134:111813. doi: 10.1016/j.ijscr.2025.111813. Epub 2025 Aug 15.
3
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms.囊液总蛋白、低密度脂蛋白胆固醇、脂质代谢产物和淋巴细胞:导管内乳头状黏液性肿瘤的不良生物标志物
Cancers (Basel). 2025 Feb 14;17(4):643. doi: 10.3390/cancers17040643.
4
A rare case of pancreatic mucinous cystic neoplasm in a pediatric patient.一名儿科患者发生胰腺黏液性囊性肿瘤的罕见病例。
JPGN Rep. 2024 Dec 13;6(1):60-64. doi: 10.1002/jpr3.12156. eCollection 2025 Feb.
5
The differential diagnosis of pancreatic cystic neoplasms with conventional ultrasound and contrast-enhanced ultrasound.胰腺囊性肿瘤的常规超声及超声造影鉴别诊断
Quant Imaging Med Surg. 2024 Jul 1;14(7):4304-4318. doi: 10.21037/qims-24-154. Epub 2024 May 28.
6
Rare tumours of the pancreas: monocentric study.胰腺罕见肿瘤:单中心研究。
J Cancer Res Clin Oncol. 2024 Jul 13;150(7):349. doi: 10.1007/s00432-024-05884-2.
7
Surgical outcomes of resected cystic neoplasms of pancreas: Experience from a tertiary care centre in India.胰腺切除囊性肿瘤的手术结果:来自印度一家三级医疗中心的经验。
Turk J Surg. 2023 Jun 19;39(2):128-135. doi: 10.47717/turkjsurg.2023.5926. eCollection 2023 Jun.
8
MiR-200b categorizes patients into pancreas cystic lesion subgroups with different malignant potential.miR-200b 可将胰腺囊性病变患者分为恶性潜能不同的亚组。
Sci Rep. 2023 Nov 14;13(1):19820. doi: 10.1038/s41598-023-47129-1.
9
Lymphoepithelial cyst mimicking malignant pancreatic signs: a case report.淋巴上皮囊肿酷似恶性胰腺征象:一例报告。
J Med Case Rep. 2023 Aug 21;17(1):359. doi: 10.1186/s13256-023-04087-6.
10
Real-Life Management of Pancreatic Cysts: Simplified Review of Current Guidelines.胰腺囊肿的实际管理:当前指南的简要回顾
J Clin Med. 2023 Jun 13;12(12):4020. doi: 10.3390/jcm12124020.

本文引用的文献

1
A War on Two Fronts: Cancer Care in the Time of COVID-19.两面作战:新冠疫情时期的癌症照护
Ann Intern Med. 2020 Jun 2;172(11):756-758. doi: 10.7326/M20-1133. Epub 2020 Mar 27.
2
COVID-19 and Italy: what next?COVID-19 和意大利:下一步如何?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
3
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma.原发性化疗治疗交界可切除和局部进展期胰腺导管腺癌的结果。
JAMA Surg. 2019 Oct 1;154(10):932-942. doi: 10.1001/jamasurg.2019.2277.
4
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis.重新评估胰腺导管腺癌手术后条件性生存的概念:一项双机构分析。
Ann Surg. 2020 Jun;271(6):1148-1155. doi: 10.1097/SLA.0000000000003083.
5
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.新辅助治疗与胰腺癌直接手术切除:术后并发症的实际情况和临床负担。
Ann Surg Oncol. 2018 Mar;25(3):626-637. doi: 10.1245/s10434-017-6281-9. Epub 2017 Dec 6.